Evidence map›Paper›PMID 38997747›Full record

ArticlePilot and feasibility studies2024

A cognitive-behavioral treatment for suicide prevention among adults with schizophrenia spectrum disorders in community mental health: Study protocol for a pilot feasibility and acceptability randomized clinical trial.

Lindsay A Bornheimer, Juliann Li Verdugo, Nicholas M Brdar, Vitalis Im, Nakea Jeffers, Courtney B Bushnell, Katie Hoener, Melisa Tasker, Krista DeWeese, Timothy Florence and 4 more

Abstract read
In one paragraph

Article in Pilot and feasibility studies, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Lindsay A BornheimerSchool of Social Work, University of Michigan, Ann Arbor, MI, USA. bornheim@umich.edu.ORCID http://orcid.org/0000-0002-4684-5696
Juliann Li VerdugoSchool of Social Work, University of Michigan, Ann Arbor, MI, USA.
Nicholas M BrdarSchool of Social Work, University of Michigan, Ann Arbor, MI, USA.
Vitalis ImSchool of Social Work, University of Michigan, Ann Arbor, MI, USA.
Nakea JeffersSchool of Social Work, University of Michigan, Ann Arbor, MI, USA.
Courtney B BushnellSchool of Social Work, University of Michigan, Ann Arbor, MI, USA.
Katie HoenerWashtenaw County Community Mental Health, Ann Arbor, MI, USA.
Melisa TaskerWashtenaw County Community Mental Health, Ann Arbor, MI, USA.
Krista DeWeeseWashtenaw County Community Mental Health, Ann Arbor, MI, USA.
Timothy FlorenceWashtenaw County Community Mental Health, Ann Arbor, MI, USA.
Jennifer M JesterSchool of Social Work, University of Michigan, Ann Arbor, MI, USA.
Cheryl A KingDepartment of Psychiatry, Michigan Medicine, Ann Arbor, MI, USA.
Stephan F TaylorDepartment of Psychiatry, Michigan Medicine, Ann Arbor, MI, USA.
Joseph A HimleSchool of Social Work, University of Michigan, Ann Arbor, MI, USA.

Funding

Feasibility, acceptability, and preliminary effectiveness of a cognitive-behavioral suicide prevention-focused intervention tailored to adults diagnosed with schizophrenia spectrum disorders2019R34MH123609 · NIMH · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BORNHEIMER, LINDSAY ANN · 2020 to 2020
$702k
NIMH NIH HHS R34 MH123609NIMH NIH HHS R34MH123609)
6 · The paper itself

Abstract

backgroundSuicide is among the leading causes of death for adults with schizophrenia spectrum disorders (SSDs), and there is a paucity of evidence-based suicide prevention-focused interventions tailored for this vulnerable population. Cognitive-Behavioral Suicide Prevention for psychosis (CBSPp) is a promising intervention developed in the UK that required modifications for delivery in community mental health (CMH) settings in the United States of American. This pilot trial evaluates the feasibility, acceptability, and preliminary effectiveness of our modified CBSPp intervention in comparison to services as usual (SAU) within a CMH setting in a Midwestern state of the USA.

methodsThis is a single-site randomized pilot trial with a planned enrollment of 60 adults meeting criteria for both SSD and SI/A. Eligible participants will be randomized 1:1 to either 10 sessions of CBSPp or SAU. Clinical and cognitive assessments will be conducted within a 4-waive design at baseline (prior to randomization and treatment) and approximately 1 month (mid-treatment), 3 months (post-treatment), and 5 months (follow-up) after baseline assessment. Qualitative interviews will also be conducted at post-treatment. The primary objective is to determine whether CBSPp is feasible and acceptable, involving examinations of recruitment rate, treatment engagement and adherence, retention and completion rates, and experiences in the CBSPp treatment and overall study. The secondary objective is to preliminarily evaluate whether modified CBSPp is associated with reductions in clinical (suicide ideation, suicide attempt, symptoms of psychosis, depression, and emergency/hospital service, hopelessness, defeat, and entrapment) and cognitive (information processing biases, appraisals, and schemas) outcomes in comparison to SAU from baseline to post-treatment assessment. DISCUSSION: This randomized pilot trial will provide clinically relevant information about whether CBSPp can improve SI/A, depression, and psychosis among adults with SSDs. Testing this modified cognitive-behavioral suicide prevention-focused intervention has the potential for a large public health impact by increasing the intervention's utility and usability in CMH where many individuals with SSDs receive care, and ultimately working towards reductions in premature suicide death.

trial registrationClinicalTrials.gov NCT#05345184. Registered on April 12, 2022.

Indexed as

Cognitive-behavioral therapyPilot clinical trialPsychosisSchizophrenia spectrum disordersSuicide

Identifiers

PMID38997747
PMCPMC11241875

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.